GlassScriptPhysician profile
David M Baratz
NPI 1104879436
$22,918.06
in general payments reported to CMS, 2019-2025
61 companies · $5,215 in 2025
The $5,215 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,965 · 2020: $2,236 · 2021: $1,482 · 2022: $3,166 · 2023: $3,951 · 2024: $4,903 · 2025: $5,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,316.05 |
| Education | $752.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,423.91 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Actelion Pharmaceuticals US, INC. | $2,337.91 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Glaxosmithkline, LLC. | $2,037.37 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Genzyme Corporation | $1,711.73 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,448.43 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,382.76 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $971.62 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $877.59 | 2021-2025 | Tyvaso, Tyvaso, Orenitram |
| Harmony Biosciences LLC | $816.19 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $779.67 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $627.94 | 2020-2025 | Acthar |
| Merck Sharp & Dohme LLC | $620.76 | 2019-2025 | Winrevair, Zerbaxa, Recarbrio |
| Axsome Therapeutics, INC. | $566.59 | 2024-2025 | Sunosi |
| Insmed, INC. | $562.43 | 2020-2025 | Arikayce, Brinsupri |
| Genentech USA, INC. | $546.19 | 2019-2025 | Xolair |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $535.81 | 2019-2024 | Yupelri |
| Electromed, INC. | $495.97 | 2021-2025 | Smartvest |
| Verona Pharma, INC. | $381.19 | 2025 | Ohtuvayre |
| Amgen INC. | $357.67 | 2022-2025 | Tezspire |
| Pulmonx Corporation | $300.44 | 2020-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Philips North America LLC | $292.04 | 2019-2025 | (6299) Dreamwear, Dreamwear, (Di7) Home Pi Undivided |
| Baxter Healthcare | $254.42 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Ani Pharmaceuticals, INC. | $243.70 | 2022-2025 | Purified Cortrophin Gel |
| Takeda Pharmaceuticals U.S.A., INC. | $205.38 | 2020-2025 | Glassia |
| Sunovion Pharmaceuticals INC. | $204.29 | 2019-2021 | |
| Ucb, INC. | $168.47 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $162.55 | 2019-2025 | |
| Zoll Respicardia, INC. | $143.23 | 2023-2025 | Remede System |
| Inspire Medical Systems, INC. | $132.05 | 2023-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $121.60 | 2023-2025 | Lumryz |
| Abbvie INC. | $119.63 | 2022-2023 | Avycaz |
| Grifols USA, LLC | $110.01 | 2023-2025 | Prolastin-C Liquid |
| Viatris Specialty LLC | $102.98 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $101.36 | 2021-2024 | Nuzyra |
| Inogen, INC. | $92.86 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen One G3 Oxygen Concentrator |
| Advanced Respiratory, INC | $80.84 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $74.75 | 2022 | |
| Gilead Sciences, INC. | $53.02 | 2019 | |
| Lilly USA, LLC | $46.92 | 2025 | Zepbound |
| Shionogi INC | $46.28 | 2022-2025 | Fetroja |
| Sandoz INC. | $45.61 | 2019-2023 | Treprostinil |
| Mayne Pharma Commercial LLC | $42.45 | 2020 | |
| Vifor Pharma, INC. | $27.26 | 2024 | Zemaira |
| Pfizer INC. | $25.23 | 2025 | |
| Aimmune Therapeutics, INC. | $23.80 | 2024 | |
| Mallinckrodt Enterprises LLC | $23.50 | 2019 | |
| Vanda Pharmaceuticals INC. | $21.13 | 2021 | |
| Phadia US INC. | $19.44 | 2023 | Immunocap |
| Csl Behring | $19.24 | 2020 | |
| Biogen, INC. | $18.83 | 2023 | Spinraza |
| Eisai INC. | $18.72 | 2022 | |
| Abiomed | $18.60 | 2025 | |
| Idorsia Pharmaceuticals US INC | $16.04 | 2023 | Quviviq |
| Nabriva Therapeutics, Plc | $15.88 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.34 | 2019 | |
| Veran Medical Technologies, INC. | $15.32 | 2020 | |
| Itamar Medical INC | $13.12 | 2022 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Baratz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.